» Articles » PMID: 6321680

Clinical-pathologic Study of Early Breast Cancer Treated by Primary Radiation Therapy

Overview
Journal J Clin Oncol
Specialty Oncology
Date 1983 Mar 1
PMID 6321680
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

We performed a clinical-pathologic review of 231 patients with early breast cancer treated by primary radiation therapy. There were 27 patients with infiltrating ductal carcinoma treated with excisional biopsy whose tumors showed a constellation of histologic features: moderate or marked intraductal carcinoma in the tumor, intraductal carcinoma in the adjacent tissue, and high nuclear grade. These patients had a 5-yr local tumor control rate of 61% compared to 96% for similar patients whose tumors did not show all three features. Radiation dose to the primary tumor area influenced the likelihood of local recurrence in these 27 patients: 15 of these patients received 6000 rads or more to the primary tumor area and had a 5-yr local tumor control rate of 84%, compared to 48% for the 12 patients who received less than 6000 rads. These results indicate that a subgroup of breast cancer patients can be identified that has a high risk of local recurrence when an insufficient radiation dose (i.e., less than 6000 rads) is delivered to the primary tumor area.

Citing Articles

Factors influencing pathological complete response and tumor regression in neoadjuvant radiotherapy and chemotherapy for high-risk breast cancer.

Haussmann J, Budach W, Nestle-Kramling C, Wollandt S, Jazmati D, Tamaskovics B Radiat Oncol. 2024; 19(1):99.

PMID: 39085866 PMC: 11293047. DOI: 10.1186/s13014-024-02450-5.


Non-Surgical Definitive Treatment for Operable Breast Cancer: Current Status and Future Prospects.

Shibamoto Y, Takano S Cancers (Basel). 2023; 15(6).

PMID: 36980750 PMC: 10046665. DOI: 10.3390/cancers15061864.


Definitive radiotherapy with stereotactic or IMRT boost with or without radiosensitization strategy for operable breast cancer patients who refuse surgery.

Shibamoto Y, Takano S, Iida M, Urano M, Ohta K, Oguri M J Radiat Res. 2022; 63(6):849-855.

PMID: 35849134 PMC: 9726698. DOI: 10.1093/jrr/rrac047.


Definitive Radiotherapy With SBRT or IMRT Boost for Breast Cancer: Excellent Local Control and Cosmetic Outcome.

Shibamoto Y, Murai T, Suzuki K, Hashizume C, Ohta K, Yamada Y Technol Cancer Res Treat. 2018; 17:1533033818799355.

PMID: 30222523 PMC: 6141921. DOI: 10.1177/1533033818799355.


Breast cancer local recurrence: risk factors and prognostic relevance of early time to recurrence.

Neri A, Marrelli D, Rossi S, De Stefano A, Mariani F, De Marco G World J Surg. 2006; 31(1):36-45.

PMID: 17180474 DOI: 10.1007/s00268-006-0097-2.